Craske MG, et al. Anxiety disorders. Nature Reviews Disease Primers. 2017;3(1):17024.
Article PubMed PubMed Central Google Scholar
APA, A.P.A., Diagnostic and statistical manual for mental disorders, 5th edition(DSM-V). 2013, Arlington, VA: American Psychiatric Publishing.
Marx W, et al. Major depressive disorder. Nat Rev Dis Primers. 2023;9(1):44.
Wilmes L, et al. Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome. Neurogastroenterol Motil. 2021;33(3):e14095.
Penninx BWJH, et al. Anxiety disorders. The Lancet. 2021;397(10277):914–27.
Butler MI, Cryan JF, Dinan TG. Man and the microbiome: A new theory of everything? Annu Rev Clin Psychol. 2019;15:371–98.
Cryan JF, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877–2013.
Article CAS PubMed Google Scholar
Morais LH, Schreiber HL, Mazmanian SK. The gut microbiota–brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2021;19(4):241–55.
Article CAS PubMed Google Scholar
Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: From motility to mood. Gastroenterology. 2021;160(5):1486–501.
Article CAS PubMed Google Scholar
Koskinen M-K, Hovatta I. Genetic insights into the neurobiology of anxiety. Trends Neurosci. 2023;46(4):318–31.
Article CAS PubMed Google Scholar
Faravelli C, et al. Childhood stressful events, HPA axis and anxiety disorders. World J Psychiatry. 2012;2(1):13–25.
Article PubMed PubMed Central Google Scholar
Zorn JV, et al. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 2017;77:25–36.
Article CAS PubMed Google Scholar
Costello H, et al. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open. 2019;9(7):e027925.
Article PubMed PubMed Central Google Scholar
Michopoulos V, et al. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017;42(1):254–70.
Article CAS PubMed Google Scholar
Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19(2):93–107.
Article PubMed PubMed Central Google Scholar
Sartori SB, Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol Ther. 2019;204:107402.
Article CAS PubMed Google Scholar
Savage K, et al. GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence. Phytother Res. 2018;32(1):3–18.
Article CAS PubMed Google Scholar
Sarris J, et al. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World J Biol Psychiatry. 2022;23(6):424–55.
Article CAS PubMed Google Scholar
Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiology of stress. 2017;7:124–36.
Article PubMed PubMed Central Google Scholar
Ratsika A, et al. Microbiota-immune-brain interactions: A lifespan perspective. Curr Opin Neurobiol. 2023;78:102652.
Article CAS PubMed Google Scholar
Gheorghe CE, et al. Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis. Curr Opin Pharmacol. 2019;48:137–45.
Article CAS PubMed Google Scholar
Butler MI, et al. The immune-kynurenine pathway in social anxiety disorder. Brain Behav Immun. 2022;99:317–26.
Article CAS PubMed Google Scholar
O’Riordan KJ, et al. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546:111572.
Article CAS PubMed Google Scholar
Erny D, et al. Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab. 2021;33(11):2260-2276.e7.
Article CAS PubMed Google Scholar
Lynch CMK, Clarke G, Cryan JF. Powering up microbiome-microglia interactions. Cell Metab. 2021;33(11):2097–9.
Article CAS PubMed Google Scholar
Morena M, et al. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology. 2016;41(1):80–102.
Article CAS PubMed Google Scholar
Cani PD, et al. Endocannabinoids–at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol. 2016;12(3):133–43.
Article CAS PubMed Google Scholar
Chevalier G, et al. Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system. Nat Commun. 2020;11(1):6363.
Article CAS PubMed PubMed Central Google Scholar
Guzzetta KE, Cryan JF, O’Leary OF. Microbiota-gut-brain axis regulation of adult hippocampal neurogenesis. Brain Plast. 2022;8(1):97–119.
Article PubMed PubMed Central Google Scholar
Nikolova VL, et al. Perturbations in gut microbiota composition in psychiatric disorders: A review and meta-analysis. JAMA Psychiat. 2021;78(12):1343–54.
Bastiaanssen TFS, et al. Making sense of … the microbiome in psychiatry. Int J Neuropsychopharmacol. 2019;22(1):37–52.
Article CAS PubMed Google Scholar
Bastiaanssen TFS, Quinn TP, Loughman A. Bugs as features (part 1): concepts and foundations for the compositional data analysis of the microbiome–gut–brain axis. Nature Mental Health. 2023;1(12):930–8.
Bastiaanssen TFS, Quinn TP, Loughman A. Bugs as features (part 2): a perspective on enriching microbiome–gut–brain axis analyses. Nature Mental Health. 2023;1(12):939–49.
Bang S, et al. Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data. Sci Rep. 2019;9(1):10189.
Article PubMed PubMed Central Google Scholar
Wakita Y, et al. Taxonomic classification for microbiome analysis, which correlates well with the metabolite milieu of the gut. BMC Microbiol. 2018;18(1):188.
Comments (0)